ArticleHuman cell2026
A model of Helicobacter infection using an artificial liver constructed by a radial-flow bioreactor.
Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Helicobacter DNA has been detected in liver tissues from patients with hepatocellular carcinoma and other liver diseases, suggesting a potential involvement of Helicobacter infection in hepatic pathogenesis. However, whether Helicobacter pylori (H. pylori) can infect human hepatocytes and how such infection affects hepatocyte structure and function remain unclear. In this study, we used a three-dimensional (3D) bioartificial liver model reconstructed using radial-flow bioreactor technology to investigate the ability of H. pylori to infect hepatocytes and to characterize the cellular responses induced by infection. Histological analysis and electron microscopy demonstrated that H. pylori adhered to the hepatocyte surface and penetrated intercellular spaces. Infection significantly induced a threefold increase in apoptosis, accompanied by upregulation of TNF-α (1.5-fold) and activation of NF-κB (1.6-fold) (all P < 0.05). In addition, PCNA expression significantly decreased to approximately 60% of control levels (P < 0.05), whereas Akt activation was enhanced and β-catenin was predominantly localized in the cytoplasm. No significant differences were observed in Ki-67, IL-8, Ets-1, or c-Met expression compared with controls. These findings demonstrate that H. pylori can infect the 3D liver model and induce apoptosis and signaling alterations in hepatocytes, suggesting a potential pathological impact on the liver. Further studies are required to determine whether similar effects occur in the human liver in vivo.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.